EC
EcoR1 Capital, LLC disclosed a 8.9% stake in FULC
EcoR1 Capital, LLC reported owning 8.9% of Fulcrum Therapeutics, Inc. (FULC) (6,803,785 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G